At a glance
The FY26 Rare Cancers Concept Award funds highly innovative, untested ideas in rare cancers and does not allow clinical trials. Eligible applicants include U.S. Department of War intramural and extramural organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; the PI must be an independent investigator at or above postdoctoral level and may be named on only one application. The program expects about $2.52 million to fund about 18 awards, with a total cost cap of $140,000 per award and a 2-year maximum period of performance; cost sharing is not required. The research must relate to rare cancers affecting six or fewer people per 100,000 per year in the United States and be relevant to active-duty Service Members, Veterans, military beneficiaries, and the American public.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Concept Award (CA) supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Applications must describe how the new idea will be innovative and present as a novel course of investigation in the field of rare cancers. Distinctive Features: Preliminary data are not required. Due to the blinded nature of the review process, identifying or making references to the Principal Investigator (PI), collaborator(s), or their organization(s) in the proposal Project Narrative, Supporting Documentations, Impact Statement, Justification Statement, and Statement of Work (SOW) is prohibited and will result in administrative rejection of the application.
Who can apply
- Unrestricted